Concepedia

Anna Permyakova

AP

Statistics

Publications

11

Citations

703

H-Index

10

Active since

2017

Affiliations

Hebrew University of Jerusalem(Current)

Hadassah Medical Center

Anna Permyakova is an author at Hebrew University of Jerusalem specializing in pharmacology, cannabinoid pharmacology, and life sciences.

ORCID

Publications per year

2017–2024

11

Publications

11

Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span

Myriam Grunewald, Saran Kumar, Husni Sharife et al. · Science · 2021 · 356 citations · Full text

, , +17

Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122

Chofit Chai, Bryan D. Cox, Dayana Yaish et al. · Gastroenterology · 2020 · 87 citations · Full text

, , +12

Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy

Liad Hinden, Shiran Udi, Adi Drori et al. · Journal of the American Society of Nephrology · 2017 · 74 citations · Full text

, , +17

Cannabinoid‐1 receptor regulates mitochondrial dynamics and function in renal proximal tubular cells

Adi Drori, Anna Permyakova, Rivka Hadar et al. · Diabetes Obesity and Metabolism · 2018 · 49 citations · Full text

, , +17

Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism

Or Kakhlon, Hilla Vaknin, Kumudesh Mishra et al. · EMBO Molecular Medicine · 2021 · 37 citations · Full text

, , +17

1–5 of 11